The first Theriva Biologics trade was made in Q3 2018.
Since then Jim Simons bought shares eleven more times and sold shares on three occasions. The investor sold all their shares in Q3 2022 and doesn't own any shares in Theriva Biologics anymore.
Avg closing price
Price range
Sold -21.9k shares
Q3 2022
Avg closing price
$1.54
Price range
$0.99
-
$2.42
Increased shares by 103.9% (+11.2k shares)
Q2 2022
Avg closing price
$2.29
Price range
$1.88
-
$2.92
Increased shares by 421.4% (+8.68k shares)
Q1 2022
Avg closing price
$2.73
Price range
$2.30
-
$4.30
New holding (+2.06k shares)
Q4 2021
Avg closing price
$3.77
Price range
$2.72
-
$4.54
Sold -124k shares
Q1 2021
Avg closing price
$7.90
Price range
$5.00
-
$11.70
Increased shares by 44.0% (+37.8k shares)
Q4 2020
Avg closing price
$3.50
Price range
$2.95
-
$4.63
Sold 3.4% shares (-2.99k shares)
Q3 2020
Avg closing price
$5.34
Price range
$4.54
-
$7.10
Increased shares by 29.2% (+20.1k shares)
Q2 2020
Avg closing price
$3.81
Price range
$2.85
-
$5.70
Increased shares by 18.4% (+10.7k shares)
Q1 2020
Avg closing price
$4.56
Price range
$2.70
-
$6.08
Increased shares by 16.0% (+8.02k shares)
Q4 2019
Avg closing price
$4.26
Price range
$3.89
-
$5.28
Increased shares by 14.9% (+6.51k shares)
Q3 2019
Avg closing price
$4.83
Price range
$3.89
-
$5.85
Increased shares by 8.6% (+3.46k shares)
Q2 2019
Avg closing price
$5.76
Price range
$4.91
-
$6.60
Increased shares by 14.5% (+5.1k shares)
Q1 2019
Avg closing price
$6.63
Price range
$5.91
-
$8.10
Increased shares by 674.3% (+30.5k shares)
Q4 2018